mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-07 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-07 |